- Home
- EYEN vs CLNN Comparison
EYEN vs CLNN Comparison
Compare EYEN & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- CLNN
- Stock Information
- Founded
- EYEN 2014
- CLNN 2012
- Country
- EYEN United States
- CLNN United States
- Employees
- EYEN N/A
- CLNN N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- EYEN Health Care
- CLNN Health Care
- Exchange
- EYEN Nasdaq
- CLNN Nasdaq
- Market Cap
- EYEN 38.2M
- CLNN 45.8M
- IPO Year
- EYEN 2018
- CLNN N/A
- Fundamental
- Price
- EYEN $0.51
- CLNN $5.34
- Analyst Decision
- EYEN Strong Buy
- CLNN Strong Buy
- Analyst Count
- EYEN 2
- CLNN 4
- Target Price
- EYEN $12.00
- CLNN $60.00
- AVG Volume (30 Days)
- EYEN 850.6K
- CLNN 72.8K
- Earning Date
- EYEN 11-11-2024
- CLNN 11-05-2024
- Dividend Yield
- EYEN N/A
- CLNN N/A
- EPS Growth
- EYEN N/A
- CLNN N/A
- EPS
- EYEN N/A
- CLNN N/A
- Revenue
- EYEN $31,405.00
- CLNN $442,000.00
- Revenue This Year
- EYEN $50,309.30
- CLNN N/A
- Revenue Next Year
- EYEN $421.63
- CLNN $1,103.39
- P/E Ratio
- EYEN N/A
- CLNN N/A
- Revenue Growth
- EYEN N/A
- CLNN N/A
- 52 Week Low
- EYEN $0.37
- CLNN $3.82
- 52 Week High
- EYEN $2.57
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- EYEN 49.88
- CLNN 49.84
- Support Level
- EYEN $0.44
- CLNN $5.36
- Resistance Level
- EYEN $0.47
- CLNN $6.10
- Average True Range (ATR)
- EYEN 0.04
- CLNN 0.50
- MACD
- EYEN 0.01
- CLNN 0.07
- Stochastic Oscillator
- EYEN 51.71
- CLNN 55.81
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).